Jack Meehan
Stock Analyst at Barclays
(3.10)
# 1,179
Out of 4,784 analysts
133
Total ratings
70.73%
Success rate
21.1%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $271 → $260 | $230.02 | +13.03% | 13 | Feb 7, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $116.69 | +7.12% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $362.16 | -20.48% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $16.18 | +103.96% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $80.00 | +306.25% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $17.70 | +7.34% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $167.33 | -40.84% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $179.07 | +0.52% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $8.88 | +12.61% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $177.39 | -6.42% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $61.32 | -29.88% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $155.55 | -1.00% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $243.00 | +76.95% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $265.82 | +61.76% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $34.89 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $42.08 | +14.07% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,177.09 | -42.23% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $122.93 | -75.60% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $500.16 | -40.02% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.41 | +2,736.88% | 1 | Dec 11, 2017 |
Labcorp Holdings
Feb 7, 2025
Maintains: Equal-Weight
Price Target: $271 → $260
Current: $230.02
Upside: +13.03%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $116.69
Upside: +7.12%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $362.16
Upside: -20.48%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $16.18
Upside: +103.96%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $80.00
Upside: +306.25%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $17.70
Upside: +7.34%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $167.33
Upside: -40.84%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $179.07
Upside: +0.52%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $8.88
Upside: +12.61%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $177.39
Upside: -6.42%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $61.32
Upside: -29.88%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $155.55
Upside: -1.00%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $243.00
Upside: +76.95%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $265.82
Upside: +61.76%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $34.89
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $42.08
Upside: +14.07%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,177.09
Upside: -42.23%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $122.93
Upside: -75.60%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $500.16
Upside: -40.02%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.41
Upside: +2,736.88%